Local Institution - 104

Dallas, Texas 75390

0 studies enrolling now · 3 studies all time

What they study most

Leukemia, Myeloid, Multiple Myeloma

Studies at this site

• Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma — Completed
• A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma — Stopped early
• A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy — Stopped early